These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 35123598

  • 1. [The Genetic and Prognostic Characteristics of AML-MRC Patients].
    Chen Z, Mu QT, Wu A, Ouyang GF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):18-21. PubMed ID: 35123598
    [Abstract] [Full Text] [Related]

  • 2. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype, TP53 deletion, and TP53 mutations.
    Wang N, Yuan L, Jing Y, Fan K, Jin H, Lv C, Wang L, Yu L.
    Leuk Lymphoma; 2021 Oct; 62(10):2466-2474. PubMed ID: 33904352
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and Cytogenetical Characteristics in Acute Myeloid Leukemia with Myelodysplasia-Related Changes].
    Ma JL, Zhou AQ, Gu SY, Chen BA, Ge Z.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1757-1762. PubMed ID: 34893106
    [Abstract] [Full Text] [Related]

  • 4. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C, Burillo-Sanz S, Morales-Camacho RM, Pérez-López O, Suito M, Vargas MT, Caballero-Velázquez T, Carrillo-Cruz E, González J, Bernal R, Pérez-Simón JA.
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [Abstract] [Full Text] [Related]

  • 5. Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype.
    Xu N, Lai YY, Chen WM, Jiang H, Wang Y, Wang X, Zhao XS, Huang XJ, Jiang Q, Qin YZ.
    Int J Lab Hematol; 2022 Oct; 44(5):892-899. PubMed ID: 35505580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A, Ades L, Baran-Marzack F, Mozziconacci MJ, Penther D, Dobbelstein S, Stamatoullas A, Récher C, Prebet T, Moulessehoul S, Fenaux P, Eclache V.
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic Factors in Acute Myeloid Leukemia With Myelodysplasia-Related Changes.
    Fang H, He R, Chiu A, Viswanatha DS, Ketterling RP, Patnaik MS, Reichard KK.
    Am J Clin Pathol; 2020 Apr 15; 153(5):656-663. PubMed ID: 31977035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
    Kirtek T, Chen W, Laczko D, Bagg A, Koduru P, Foucar K, Venable E, Nichols M, Rogers HJ, Tam W, Orazi A, Hsi ED, Hasserjian RP, Wang SA, Arber DA, Weinberg OK.
    Leuk Res; 2023 Jul 15; 130():107309. PubMed ID: 37210875
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R, Mansat-De Mas V, Gelsi-Boyer V, Demur C, Murati A, Corre J, Prebet T, Bertoli S, Brecqueville M, Arnoulet C, Recher C, Vey N, Mozziconacci MJ, Delabesse E, Birnbaum D.
    Oncotarget; 2015 Apr 10; 6(10):8388-96. PubMed ID: 25860933
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT.
    Poiré X, Labopin M, Polge E, Forcade E, Ganser A, Volin L, Michallet M, Blaise D, Yakoub-Agha I, Maertens J, Espiga CR, Cornelissen J, Finke J, Mohty M, Esteve J, Nagler A.
    Haematologica; 2020 Apr 10; 105(2):414-423. PubMed ID: 31048355
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.